In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

By Kamal Choudhury and Mariam Sunny Jan 20 (Reuters) - Moderna and Merck said on Tuesday their experimental personalized ...

Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...

A study has found that COVID-19 mRNA vaccines unexpectedly enhance the effectiveness of immunotherapy for lung and skin cancer. Researchers at the MD Anderson Cancer Center in Texas, U.S., revealed ...

At the World Economic Forum, CEO Stéphane Bancel expressed concern about the US vaccine market but remained committed to cancer and rare disease mRNA programs.

A few years before he took over the U.S. Department of Health and Human Services, Robert F. Kennedy Jr. called COVID-19 shots the "deadliest vaccine ever made." More recently, various anti-vaccination ...

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: a precisely timed mRNA shot could help many cancer patients live longer. The work still requires ...

If promising results on a skin cancer vaccine from Moderna and Merck lead to a new launch, the Covid-19 era darling's stock could revive after a 91% fall from its peak.

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine ...